Literature DB >> 20656929

Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease.

John J Strouse1, Megan E Reller, David G Bundy, Martha Amoako, Maria Cancio, Rachel N Han, Alexandra Valsamakis, James F Casella.   

Abstract

Influenza causes excess morbidity in sickle cell disease (SCD). H1N1 pandemic influenza has been severe in children. To compare H1N1 with seasonal influenza in SCD (patients younger than 22), we reviewed medical records (1993-2009). We identified 123 cases of laboratory-confirmed influenza (94 seasonal, 29 H1N1). Those with seasonal influenza were younger (median 4.4 vs 8.7 years old, P = .006) and had less asthma (24% vs 56%, P = .002). Those with H1N1 influenza more often had acute chest syndrome (ACS; 34% vs 13%, P = .01) and required intensive care (17% vs 3%, P = .02), including mechanical ventilation (10% vs 0%, P = .02). In multivariate analysis, older age (odds ratio [OR] 1.1 per year, P = .04) and H1N1 influenza (OR 3.0, P = .04) were associated with ACS, and older age (OR 1.1 per year, P = .02) and prior ACS (OR 3.3 per episode in last year, P < .006) with intensive care. Influenza, especially H1N1, causes critical illness in SCD and should be prevented.

Entities:  

Mesh:

Year:  2010        PMID: 20656929      PMCID: PMC2981471          DOI: 10.1182/blood-2010-05-282194

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia.

Authors:  Alessandra R Souza; Josefina A P Braga; Terezinha M de Paiva; Sandra R Loggetto; Raymundo S Azevedo; Lily Y Weckx
Journal:  Vaccine       Date:  2010-01-22       Impact factor: 3.641

2.  Response to a monovalent 2009 influenza A (H1N1) vaccine.

Authors:  Michael E Greenberg; Michael H Lai; Gunter F Hartel; Christine H Wichems; Charmaine Gittleson; Jillian Bennet; Gail Dawson; Wilson Hu; Connie Leggio; Diane Washington; Russell L Basser
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

3.  A novel influenza A (H1N1) vaccine in various age groups.

Authors:  Feng-Cai Zhu; Hua Wang; Han-Hua Fang; Jian Guo Yang; Xiao Jun Lin; Xiao-Feng Liang; Xue-Feng Zhang; Hong-Xing Pan; Fan-Yue Meng; Yue Mei Hu; Wen-Dong Liu; Chang-Gui Li; Wei Li; Xiang Zhang; Jin Mei Hu; Wei Bing Peng; Bao Ping Yang; Pei Xi; Hua-Qing Wang; Jing-Shan Zheng
Journal:  N Engl J Med       Date:  2009-10-21       Impact factor: 91.245

4.  The number of people with sickle-cell disease in the United States: national and state estimates.

Authors:  David C Brousseau; Julie A Panepinto; Mark Nimmer; Raymond G Hoffmann
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

5.  Clinical presentation of influenza in unselected children treated as outpatients.

Authors:  Heli Silvennoinen; Ville Peltola; Pasi Lehtinen; Raija Vainionpää; Terho Heikkinen
Journal:  Pediatr Infect Dis J       Date:  2009-05       Impact factor: 2.129

6.  Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Scott A Harper; John S Bradley; Janet A Englund; Thomas M File; Stefan Gravenstein; Frederick G Hayden; Allison J McGeer; Kathleen M Neuzil; Andrew T Pavia; Michael L Tapper; Timothy M Uyeki; Richard K Zimmerman
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

7.  Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza.

Authors:  Sean O'Riordan; Michelle Barton; Yvonne Yau; Stanley E Read; Upton Allen; Dat Tran
Journal:  CMAJ       Date:  2009-11-19       Impact factor: 8.262

8.  Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries.

Authors:  Nancy F Crum-Cianflone; Patrick J Blair; Dennis Faix; John Arnold; Sara Echols; Sterling S Sherman; John E Tueller; Tyler Warkentien; Gabriela Sanguineti; Mary Bavaro; Braden R Hale
Journal:  Clin Infect Dis       Date:  2009-12-15       Impact factor: 9.079

9.  Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

Authors:  Tristan W Clark; Manish Pareek; Katja Hoschler; Helen Dillon; Karl G Nicholson; Nicola Groth; Iain Stephenson
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

10.  Burden of influenza-related hospitalizations among children with sickle cell disease.

Authors:  David G Bundy; John J Strouse; James F Casella; Marlene R Miller
Journal:  Pediatrics       Date:  2010-01-25       Impact factor: 7.124

View more
  32 in total

Review 1.  Pulmonary complications of sickle cell disease.

Authors:  Andrew C Miller; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2012-03-23       Impact factor: 21.405

2.  Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli.

Authors:  Margaret F Bennewitz; Maritza A Jimenez; Ravi Vats; Egemen Tutuncuoglu; Jude Jonassaint; Gregory J Kato; Mark T Gladwin; Prithu Sundd
Journal:  JCI Insight       Date:  2017-01-12

3.  The impact of the 2009 H1N1 influenza pandemic on pediatric patients with sickle cell disease.

Authors:  Alex George; Jennifer Benton; Jesse Pratt; Mi-Ok Kim; Karen A Kalinyak; Theodosia A Kalfa; Clinton H Joiner
Journal:  Pediatr Blood Cancer       Date:  2011-02-25       Impact factor: 3.167

4.  Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients.

Authors:  Su-Mi Choi; Alexandre A Boudreault; Hu Xie; Janet A Englund; Lawrence Corey; Michael Boeckh
Journal:  Blood       Date:  2011-03-03       Impact factor: 22.113

5.  Respiratory syncytial virus and seasonal influenza cause similar illnesses in children with sickle cell disease.

Authors:  Sara Christina Sadreameli; Megan E Reller; David G Bundy; James F Casella; John J Strouse
Journal:  Pediatr Blood Cancer       Date:  2014-01-31       Impact factor: 3.167

Review 6.  Indications for transfusion in the management of sickle cell disease.

Authors:  Hyojeong Han; Lisa Hensch; Venée N Tubman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

7.  Influenza vaccine effectiveness and disease burden in children and adolescents with sickle cell disease: 2012-2017.

Authors:  Carol M Kao; Kristina Lai; John M McAteer; Mohnd Elmontser; Elizabeth M Quincer; Marianne E M Yee; Ashley Tippet; Robert C Jerris; Peter A Lane; Evan J Anderson; Nitya Bakshi; Inci Yildirim
Journal:  Pediatr Blood Cancer       Date:  2020-05-29       Impact factor: 3.167

Review 8.  A Comprehensive Review of the Treatment and Management of Pain in Sickle Cell Disease.

Authors:  Jacob Fiocchi; Ivan Urits; Vwaire Orhurhu; Mariam Salisu Orhurhu; Stephen Giacomazzi; Briggs Hoyt; Alan D Kaye; Rachel J Kaye; Omar Viswanath
Journal:  Curr Pain Headache Rep       Date:  2020-03-21

Review 9.  Wheezing in children with sickle cell disease.

Authors:  Jeffrey A Glassberg; Robert Strunk; Michael R DeBaun
Journal:  Curr Opin Pediatr       Date:  2014-02       Impact factor: 2.856

10.  Platelet Extracellular Vesicles Drive Inflammasome-IL-1β-Dependent Lung Injury in Sickle Cell Disease.

Authors:  Ravi Vats; Tomasz Brzoska; Margaret F Bennewitz; Maritza A Jimenez; Tirthadipa Pradhan-Sundd; Egemen Tutuncuoglu; Jude Jonassaint; Edgar Gutierrez; Simon C Watkins; Sruti Shiva; Melanie J Scott; Adrian E Morelli; Matthew D Neal; Gregory J Kato; Mark T Gladwin; Prithu Sundd
Journal:  Am J Respir Crit Care Med       Date:  2020-01-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.